Clinical Trials · NCT02603679
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Thomas Hatschek
- Enrollment
- 181
- Start date
- Feb 2015
- Locations
- 3 sites, Sweden
- Primary endpoint
- Radiological Objective Response Rate after Completion of the First 12-week Period of Primary Medical Treatment